The secretome signature of colon cancer cell lines

Journal of Cellular Biochemistry

Volumn 114, Issue 11, 2013, Pages 2577-2587

  Imperlini, Esther ^a   Colavita, Irene ^b   Caterino, Marianna ^a   Mirabelli, Peppino ^a   Pagnozzi, Daniela ^c   Vecchio, Luigi Del ^b,d   Noto, Rosa Di ^b,d   Ruoppolo, Margherita ^b,d   Orrù, Stefania ^a,e  

^a IRCCS SDN   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c Porto Conte Ricerche Srl   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

CACO 2; Colon Cancer; HCT GEO; Proteomics; Secretome

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; COLON CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SCORING SYSTEM;

CACO-2; COLON CANCER; HCT-GEO; PROTEOMICS; SECRETOME;

BLOTTING, WESTERN; CACO-2 CELLS; CELL LINE, TUMOR; COLONIC NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84884249506     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24600     Document Type: Article

References (56)

1. Bhattacharya A, Turowski SG, San Martin ID, Rajput A, Rustum YM, Hoffman RM, Seshadri M,. 2001. Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer. Anticancer Res 31: 387-393.
2. Bendtsen JD, Jensen LJ, Blom N, von Heijne G, Brunak S,. 2004. SecretomeP: Feature based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 17: 349-356.
3. Caterino M, Corbo C, Imperlini E, Armiraglio M, Pavesi E, Aspesi A, Loreni F, Dianzani I, Ruoppolo M,. 2013. Differential proteomic analysis in human cells subjected to ribosomal stress. Proteomics 13: 1220-1227.
4. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A,. 1988. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: A survey of twenty cell lines. Cancer Res 48: 1936-1942.
5. Chen R, Tan Y, Wang M, Wang F, Yao Z, Dong L, Ye M, Wang H, Zou H,. 2011. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol Cell Proteomics 10: 1-13.
6. Chew A, Salama P, Robbshaw A, Klopcic B, Zeps N, Platell C, Lawrance IC,. 2011. SPARC, FOXP3, CD8, and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer. PLoS ONE 6: e22047.
7. Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR,. 2012. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Int J Oncol 41: 211-218.
8. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A,. 2002. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 16: 2058-2072.
9. Corbo C, Orrù S, Gemei M, Noto RD, Mirabelli P, Imperlini E, Ruoppolo M, Vecchio LD, Salvatore F,. 2012. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity. Proteomics 12: 2045-2059.
10. de Bruïne AP, de Vries JE, Dinjens WN, Moerkerk PT, van der Linden EP, Pijls MM, ten Kate J, Bosman FT,. 1993. Human Caco-2 cells transfected with c-Ha-Ras as a model for endocrine differentiation in the large intestine. Differentiation 53: 51-60.
11. De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M,. 2004. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 18: 1016-1018.
12. Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE, Monard D,. 2009. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res 69: 5690-5698.
13. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø,. 2004. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 40: 1593-1598.
14. Fujita M, Khazenzon NM, Bose S, Sekiguchi K, Sasaki T, Carter WG, Ljubimov AV, Black KL, Ljubimova JY,. 2005. Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 7: R411-R421.
15. Gemei M, Mirabelli P, Di Noto R, Corbo C, Iaccarino A, Zamboli A, Troncone G, Galizia G, Lieto E, Del Vecchio L, Salvatore F,. 2013. CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Cancer 119: 729-738.
16. Girotti MR, Fernández M, Lõpez JA, Camafeita E, Fernández EA, Albar JP, Benedetti LG, Valacco MP, Brekken RA, Podhajcer OL, Llera AS,. 2011. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis. J Invest Dermatol 131: 2438-2447.
17. Hayashi H, Nabeshima K, Aoki M, Hamasaki M, Enatsu S, Yamauchi Y, Yamashita Y, Iwasaki H,. 2010. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion. Int J Cancer 126: 2563-2574.
18. He X, Zheng Z, Li J, Ben Q, Liu J, Zhang J, Ji J, Yu B, Chen X, Su L, Zhou L, Liu B, Yuan Y,. 2012. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. Carcinogenesis 33: 555-562.
19. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. 2008. Cancer statistics. CA Cancer J Clin 58: 71-96.
20. Ji H, Goode RJ, Vaillant F, Mathivanan S, Kapp EA, Mathias RA, Lindeman GJ, Visvader JE, Simpson RJ,. 2011. Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations. Proteomics 11: 4029-4039.
21. Kadowaki M, Sangai T, Nagashima T, Sakakibara M, Yoshitomi H, Takano S, Sogawa K, Umemura H, Fushimi K, Nakatani Y, Nomura F, Miyazaki M,. 2011. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach. J Cancer Res Clin Oncol 137: 1105-1115.
22. Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, Fujii T, Nishikawa Y, Sugimoto H, Takeda S, Nakao A,. 2011. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinog 50: 571-579.
23. Kashat L, So AK, Masui O, Wang XS, Cao J, Meng X, Macmillan C, Ailles LE, Siu KW, Ralhan R, Walfish PG,. 2010. Secretome-based identification and characterization of potential biomarkers in thyroid cancer. J Proteome Res 9: 5757-5769.
24. Kim Y, Jang M, Lim S, Won H, Yoon KS, Park JH, Kim HJ, Kim BH, Park WS, Ha J, Kim SS,. 2011. Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans. Hepatology 54: 1661-1678.
25. Klein-Scory S, Kubler S, Diehl H, Eilert-Micus C, Reinacher-Schick A, Stuhler K, Warscheid B, Meyer HE, Schmiegel W, Schwarte-Waldhoff I,. 2010. Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer 10: 70-88.
26. Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A,. 2011. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell 22: 1121-1134.
27. Kroepil F, Fluegen G, Totikov Z, Baldus SE, Vay C, Schauer M, Topp SA, Esch JS, Knoefel WT, Stoecklein NH,. 2012. Down-regulation of CDH1 Is associated with expression of snai1 in colorectal adenomas. PLoS ONE 7: e46665.
28. Kulasingam V, Diamandis EP,. 2008. Tissue culture-based breast cancer biomarker discovery platform. Int J Cancer 123: 2007-2012.
29. Imperlini E, Mancini A, Spaziani S, Martone D, Alfieri A, Gemei M, Del Vecchio L, Buono P, Orrù S,. 2010. Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. Proteomics 10: 3165-3175.
30. Laska DL, Houchins JO, Pratt SE, Horn J, Xia X, Hanssen BR, Williams DC, Dantzig AH, Lindstrom AE,. 2002. Characterization and application of a vinblastine-selected caco-2 cell line for evaluation of p-glycoprotein in vitro cell. Dev Biol Animal 38: 401-410.
31. Lau LF,. 2011. CCN1/CY R61: The very model of a modern matricellular protein. Cell Mol Life Sci 68: 3149-3163.
32. Ma Y, Visser L, Roelofsen H, de Vries M, Diepstra A, van Imhoff G, van der Wal T, Luinge M, Alvarez-Llamas G, Vos H, Poppema S, Vonk R, van den Berg A,. 2008. Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 111: 2339-2346.
33. Makridakis M, Vlahou A,. 2010. Secretome proteomics for discovery of cancer biomarkers. J Proteomics 73: 2291-2305.
34. Mathivanan S, Ji H, Simpson RJ,. 2010. Exosomes: Extracellular organelles importantin intercellular communication. J Proteomics 73: 1907-1920.
35. Mustafa D, van der Weiden M, Zheng P, Nigg A, Luider TM, Kros JM,. 2010. Expression sites of colligin 2 in glioma blood vessels. Brain Pathol 20: 50-65.
36. Normanno N, Bianco C, Damiano V, de Angelis E, Selvam MP, Grassi M, Magliulo G, Tortora G, Bianco AR, Mendelsohn J, Salomon DS, Ciardiello F,. 1996. Growth Inhibition of Human Colon Carcinoma Cells by Combinations of Anti-Epidermal Growth Factor-related Growth Factor Antisense Oligonucleotides. Clin Cancer Res 2: 601-609.
37. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG,. 2005. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 4: 1487-1502.
38. Orrù S, Ruoppolo M, Francese S, Vitagliano L, Marino G, Esposito C,. 2002. Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase. Protein Sci 11: 137-146.
39. Park JH, Seol JA, Choi HJ, Roh YH, Choi PJ, Lee KE, Roh MS,. 2011. Comparison of cadherin-17 expression between primary colorectal adenocarcinomas and their corresponding metastases: The possibility of a diagnostic marker for detecting the primary site of metastatic tumour. Histopathology 58: 315-318.
40. Petersen TN, Brunak S, von Heijne G, Nielsen H,. 2011. SignalP 4.0: Discriminating signal peptides from transmembrane regions. Nature Methods 8: 785-786.
41. Rodríguez-Piñeiro AM, García-Lorenzo A, Blanco-Prieto S, Alvarez-Chaver P, Rodríguez-Berrocal FJ, Cadena MP, Martínez-Zorzano VS,. 2012. Secreted clusterin in colon tumor cell models and its potential as diagnostic marker for colorectal cancer. Cancer Invest 30: 72-78.
42. Sato Y, Kumamoto K, Saito K, Okayama H, Hayase S, Kofunato Y, Miyamoto K, Nakamura I, Ohki S, Koyama Y, Takenoshita S,. 2011. Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis. Exp Ther Med 2: 239-243.
43. Scamuffa N, Metrakos P, Calvo F, Khatib AM,. 2011. Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cells. Methods Mol Biol 768: 207-215.
44. Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli G, Trentini GP, Cittadini A,. 2003. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 162: 849-860.
45. Simpson RJ, Jensen SS, Lim JW,. 2008. Proteomic profiling of exosomes: Current perspectives. Proteomics 8: 4083-4099.
46. Susila A, Chan H, Loh AX, Phang HQ, Wong ET, Tergaonkar V, Koh CG,. 2010. The POPX2 phosphatase regulates cancer cell motility and invasiveness. Cell Cycle 9: 179-187.
47. Swaminathan G, Cartwright CA,. 2012. Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis. Oncogene 31: 376-389.
48. Tsutsumi S, Fukasawa T, Yamauchi H, Kato T, Kigure W, Morita H, Asao T, Kuwano H,. 2009. Phosphoglucose isomerase enhances colorectal cancer metastasis. Int J Oncol 35: 1117-1121.
49. Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J, Niu R,. 2012. Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif 45: 189-198.
50. Wu CC, Chen HC, Chen SJ, Liu HP, Hsieh YY, Yu CJ, Tang R, Hsieh LL, Yu JS, Chang YS,. 2008. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 8: 316-332.
51. Wu CC, Hsu CW, Chen CD, Yu CJ, Chang KP, Tai DI, Liu HP, Su WH, Chang YS, Yu JS,. 2010. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 9: 1100-1117.
52. Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH,. 2009. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. J Clin Gastroenterol 43: 831-837.
53. Xue H, Lu B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M,. 2010. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 9: 545-555.
54. Yakovich AJ, Huang Q, Du J, Jiang B, Barnard JA,. Vectorial TGFbeta signaling in polarized intestinal epithelial cells. J Cell Physiol 2010. 224: 398-404.
55. Zheng Q, Wang XJ,. 2008. GOEAST: A web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 36: W358-W363.
56. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP,. 2006. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 5: 2339-2347.